Records containing: Stage IV Pancreatic Cancer

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2020-12-30
A Phase 2 Study of Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2020-12-17
Phase II Study of Antineoplastons A10 and AS2-1 in Patients With Adenocarcinoma of the Pancreas
CLINICAL_TRIALS study record update · 2020-09-09
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
CLINICAL_TRIALS study record update · 2020-09-09
A Phase 1b Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
CLINICAL_TRIALS study record update · 2020-05-08
A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2020-05-06
Nivolumab as add-on to Gemcitabine/S-1 in Metastatic Pancreatic Cancer: a Phase II Trial
CLINICAL_TRIALS study record update · 2020-03-06
Ipilimumab and Gemcitabine for Advanced Pancreas Cancer: A Phase Ib Study
CLINICAL_TRIALS study record update · 2020-01-23
A Randomized Trial of a Family Caregiver Palliative Care Intervention
CLINICAL_TRIALS study record update · 2020-01-18
A Pilot Study of Intravenous Ascorbic Acid and Folfirinox in the Treatment of Advanced Pancreatic Cancer
CLINICAL_TRIALS study record update · 2019-09-06
Phase 1-2 18F-FPPRGD2 PET/CT or PET/MRI Imaging of αvβ3 Integrins Expression as a Biomarker of Angiogenesis
CLINICAL_TRIALS study record update · 2019-05-29
A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
CLINICAL_TRIALS study record update · 2019-04-08
Phase I Trial of The Combination of Vismodegib and Sirolimus
CLINICAL_TRIALS study record update · 2018-12-27
A Pilot Study: Open-Label Clinical Trial of CPI-613 in Patients With Metastatic Pancreatic Adenocarcinoma and Poor Performance Status
CLINICAL_TRIALS study record update · 2018-11-30
A Phase 1b/2 Multicenter, International, Randomized, Double Blind, Placebo-Controlled, Study of Gemcitabine Combined With PEGPH20 Compared to Gemcitabine Combined With Placebo in Patients With Stage IV Previously Untreated Pancreatic Cancer
CLINICAL_TRIALS study record update · 2018-08-28
Phase II, Open Label Study of Intravenous Ascorbic Acid in Combination With Gemcitabine and Erlotinib in the Treatment of Metastatic Pancreatic Cancer
CLINICAL_TRIALS study record update · 2018-07-03
A Phase 1, Open-Label, Dose-Ranging Study to Assess the Safety and Immunologic Activity of APN401
CLINICAL_TRIALS study record update · 2018-02-07
A 2-arm Randomized Phase II Study of Carboplatin, Paclitaxel Plus Reovirus Serotype-3 Dearing Strain (Reolysin) vs. Carboplatin and Paclitaxel in the First Line Treatment of Patients With Recurrent or Metastatic Pancreatic Cancer
CLINICAL_TRIALS study record update · 2017-12-04
A Phase II Study Evaluating Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel in the First Line Treatment of Surgically Unresectable/Metastatic Pancreatic Cancer
CLINICAL_TRIALS study record update · 2017-08-01
A Phase I Study of an MVA Vaccine Targeting P53 in Cancer
CLINICAL_TRIALS study record update · 2017-03-22
Phase I Trial of Intra-tumoral Gemcitabine Therapy for Locally Advanced Pancreatic Carcinoma
CLINICAL_TRIALS study record update · 2016-12-09
A Phase II Study of the Halichondrin B Analog E7389 as Second Line Therapy for Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
CLINICAL_TRIALS study record update · 2016-11-07
A Phase 2 Study of AZD6244 Plus Erlotinib for the Second-Line Treatment of Advanced Pancreatic Adenocarcinoma
CLINICAL_TRIALS study record update · 2016-08-18
A Phase II Study of Induction Consolidation and Maintenance Approach for Patients With Advanced Pancreatic Cancer
CLINICAL_TRIALS study record update · 2016-05-20
A Phase Ib/II Study of BGJ398 in Combination Modified FOLFIRINOX in Treatment-Naïve Metastatic Pancreatic Cancer Patients
CLINICAL_TRIALS study record update · 2016-03-09
Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs mFOLFOX in Patients With Metastatic Pancreatic Cancer After Prior Chemotherapy